Research and Markets: Cell Isolation/Cell Separation Market Outlook 2019: Key Vendors are BD Biosciences, Danaher, GE, Merck Millipore, Miltenyi Biotec, pluriSelect, STEMCELL, Sigma-Aldrich, Terumo BCT, Thermo Fisher Scientific

Research and Markets (http://www.researchandmarkets.com/research/6j28ct/cell) has announced the addition of the "Cell Isolation/Cell Separation Market by Product, Cell Type, Technique, Application & by End user - Forecast to 2019" report to their offering.

The global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019

The cell separation market is segmented on the basis of product, cell type, technique, application, enduser, and geography.

The global cell isolation market involves various products that help in separating specific cells from a tissue or a sample.

This market is driven by several factors which include increasing usage of cell separation in cancer research, increasing number of biotechnology and biopharmaceutical industries, technological advancements, high prevalence of infectious diseases, rising aging population, and growth in government investments. The relatively untapped Asian market and increasing number of stem cell research have opened an array of opportunities for growth of the market. However, reluctance amongst researchers to use advanced cell separation techniques and high cost of instruments are expected to restrain the growth of this market.

The global cell isolation market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the global cell separation market in the forecast period, followed by Europe. Over the next five years, the growth of the global market in the Asian region is likely to be centered on China, Japan, Malaysia, and India.

Report Scope

Product

• Reagent
• Media
• Bead
• Centrifuge

Cell Type

• Human
• Stem cell
• Animal

Technique

• Filtration
• Surface Marker

Application

• Research
• IVD
  

End user

• Hospital
• Biotechnology
  

Companies Mentioned

• Beckman Coulter (Subsidiary of Danaher Corporation)
• Becton Dickinson and Company
• GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
• Merck Millipore (A Segment of Merck KGAA)
• Miltenyi Biotec
• Pluriselect Life Science
• Sigma-Aldrich Corporation
• Stemcell Technologies
• Terumo BCT (A Subsidiary of Terumo Corporation)
• Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/6j28ct/cell